Amedeo Smart

Free Medical Literature Service


 

Amedeo

COVID-19

  Free Subscription

Articles published in
J Virol
    August 2022
  1. UNDI RB, Larabee JL, Filiberti A, Ulahannan S, et al
    Targeting Doublecortin-Like Kinase 1 (DCLK1)-Regulated SARS-CoV-2 Pathogenesis in COVID-19.
    J Virol. 2022 Aug 9:e0096722. doi: 10.1128/jvi.00967.
    >> Share

  2. ANDERSON-DANIELS J, Gribble J, Denison M
    Proteolytic Processing of the Coronavirus Replicase Nonstructural Protein 14 Exonuclease Is Not Required for Virus Replication but Alters RNA Synthesis and Viral Fitness.
    J Virol. 2022 Aug 4:e0084122. doi: 10.1128/jvi.00841.
    >> Share

  3. ABDELNABI R, Foo CS, Kaptein SJF, Boudewijns R, et al
    A SCID Mouse Model To Evaluate the Efficacy of Antivirals against SARS-CoV-2 Infection.
    J Virol. 2022 Aug 4:e0075822. doi: 10.1128/jvi.00758.
    >> Share

  4. CAMPAGNOLA G, Govindarajan V, Pelletier A, Canard B, et al
    The SARS-CoV nsp12 Polymerase Active Site Is Tuned for Large-Genome Replication.
    J Virol. 2022 Aug 4:e0067122. doi: 10.1128/jvi.00671.
    >> Share

  5. ZHAN W, Tian X, Zhang X, Xing S, et al
    Structural Study of SARS-CoV-2 Antibodies Identifies a Broad-Spectrum Antibody That Neutralizes the Omicron Variant by Disassembling the Spike Trimer.
    J Virol. 2022 Aug 4:e0048022. doi: 10.1128/jvi.00480.
    >> Share

  6. LI Z, Fang P, Duan P, Chen J, et al
    Porcine Deltacoronavirus Infection Cleaves HDAC2 to Attenuate Its Antiviral Activity.
    J Virol. 2022 Aug 2:e0102722. doi: 10.1128/jvi.01027.
    >> Share

  7. YUAN M, Chen X, Zhu Y, Dong X, et al
    A Bispecific Antibody Targeting RBD and S2 Potently Neutralizes SARS-CoV-2 Omicron and Other Variants of Concern.
    J Virol. 2022 Aug 2:e0077522. doi: 10.1128/jvi.00775.
    >> Share

    July 2022
  8. FROLOVA EI, Palchevska O, Lukash T, Dominguez F, et al
    Acquisition of Furin Cleavage Site and Further SARS-CoV-2 Evolution Change the Mechanisms of Viral Entry, Infection Spread, and Cell Signaling.
    J Virol. 2022 Jul 25:e0075322. doi: 10.1128/jvi.00753.
    >> Share

  9. AKAISHI T, Horii A, Ishii T
    Sequence Exchange Involving Dozens of Consecutive Bases with External Origin in SARS-Related Coronaviruses.
    J Virol. 2022 Jul 20:e0100222. doi: 10.1128/jvi.01002.
    >> Share

  10. GUO H, Li A, Lin HF, Liu MQ, et al
    The Glycan-Binding Trait of the Sarbecovirus Spike N-Terminal Domain Reveals an Evolutionary Footprint.
    J Virol. 2022 Jul 19:e0095822. doi: 10.1128/jvi.00958.
    >> Share

  11. MOYO-GWETE T, Madzivhandila M, Mkhize NN, Kgagudi P, et al
    Shared N417-Dependent Epitope on the SARS-CoV-2 Omicron, Beta, and Delta Plus Variants.
    J Virol. 2022 Jul 13:e0055822. doi: 10.1128/jvi.00558.
    >> Share

  12. DONG S, Kong N, Wang C, Li Y, et al
    FUBP3 Degrades the Porcine Epidemic Diarrhea Virus Nucleocapsid Protein and Induces the Production of Type I Interferon.
    J Virol. 2022;96:e0061822.
    >> Share

  13. PUSNIK J, Konig J, Mai K, Richter E, et al
    Persistent Maintenance of Intermediate Memory B Cells Following SARS-CoV-2 Infection and Vaccination Recall Response.
    J Virol. 2022 Jul 12:e0076022. doi: 10.1128/jvi.00760.
    >> Share

  14. CHAPARIAN RR, Harding AT, Hamele CE, Riebe K, et al
    A Virion-Based Combination Vaccine Protects against Influenza and SARS-CoV-2 Disease in Mice.
    J Virol. 2022 Jul 12:e0068922. doi: 10.1128/jvi.00689.
    >> Share

  15. OISHI K, Horiuchi S, Minkoff JM, tenOever BR, et al
    The Host Response to Influenza A Virus Interferes with SARS-CoV-2 Replication during Coinfection.
    J Virol. 2022 Jul 12:e0076522. doi: 10.1128/jvi.00765.
    >> Share

  16. AICHER SM, Streicher F, Chazal M, Planas D, et al
    Species-Specific Molecular Barriers to SARS-CoV-2 Replication in Bat Cells.
    J Virol. 2022 Jul 5:e0060822. doi: 10.1128/jvi.00608.
    >> Share

  17. XING N, Wang Z, Wang J, Nascimento M, et al
    Engineering and Characterization of Avian Coronavirus Mutants Expressing Fluorescent Reporter Proteins from the Replicase Gene.
    J Virol. 2022 Jul 5:e0065322. doi: 10.1128/jvi.00653.
    >> Share

    June 2022
  18. VAN OOSTEN L, Yan K, Rawle DJ, Le TT, et al
    An S1-Nanoparticle Vaccine Protects against SARS-CoV-2 Challenge in K18-hACE2 Mice.
    J Virol. 2022 Jun 29:e0084422. doi: 10.1128/jvi.00844.
    >> Share

  19. JIANG C, Li L, Xue M, Zhao L, et al
    Long-Term Expanding Porcine Airway Organoids Provide Insights into the Pathogenesis and Innate Immunity of Porcine Respiratory Coronavirus Infection.
    J Virol. 2022 Jun 28:e0073822. doi: 10.1128/jvi.00738.
    >> Share

  20. DIEBOLD O, Gonzalez V, Venditti L, Sharp C, et al
    Using Species a Rotavirus Reverse Genetics to Engineer Chimeric Viruses Expressing SARS-CoV-2 Spike Epitopes.
    J Virol. 2022 Jun 27:e0048822. doi: 10.1128/jvi.00488.
    >> Share

  21. YUAN C, Zhang P, Liu P, Li Y, et al
    A Novel Pathway for Porcine Epidemic Diarrhea Virus Transmission from Sows to Neonatal Piglets Mediated by Colostrum.
    J Virol. 2022 Jun 27:e0047722. doi: 10.1128/jvi.00477.
    >> Share

  22. BI W, Chen G, Dang B
    Novel Engineered SARS-CoV-2 HR1 Trimer Exhibits Improved Potency and Broad-Spectrum Activity against SARS-CoV-2 and Its Variants.
    J Virol. 2022 Jun 23:e0068122. doi: 10.1128/jvi.00681.
    >> Share

  23. CHAN CE, Ng CG, Lim AP, Seah SL, et al
    The Cellular Characterization of SARS-CoV-2 Spike Protein in Virus-Infected Cells Using the Receptor Binding Domain Binding Specific Human Monoclonal Antibodies.
    J Virol. 2022 Jun 21:e0045522. doi: 10.1128/jvi.00455.
    >> Share

  24. LIN J, Law R, Korosec CS, Zhou C, et al
    Longitudinal Assessment of SARS-CoV-2-Specific T Cell Cytokine-Producing Responses for 1 Year Reveals Persistence of Multicytokine Proliferative Responses, with Greater Immunity Associated with Disease Severity.
    J Virol. 2022 Jun 14:e0050922. doi: 10.1128/jvi.00509.
    >> Share

  25. SUN C, Yuan RY, Xie C, Sun JF, et al
    Induction of Broadly Cross-Reactive Antibody Responses to SARS-CoV-2 Variants by S1 Nanoparticle Vaccines.
    J Virol. 2022 Jun 14:e0038322. doi: 10.1128/jvi.00383.
    >> Share

  26. LAVIE M, Dubuisson J, Belouzard S
    SARS-CoV-2 Spike Furin Cleavage Site and S2' Basic Residues Modulate the Entry Process in a Host Cell-Dependent Manner.
    J Virol. 2022 Jun 9:e0047422. doi: 10.1128/jvi.00474.
    >> Share

  27. SEVENICH M, van den Heuvel J, Gering I, Mohrluder J, et al
    A So-Far Overlooked Secondary Conformation State in the Binding Mode of SARS-CoV-2 Spike Protein to Human ACE2 and Its Conversion Rate Are Crucial for Estimating Infectivity Efficacy of the Underlying Virus Variant.
    J Virol. 2022 Jun 8:e0068522. doi: 10.1128/jvi.00685.
    >> Share

  28. ESSALMANI R, Jain J, Susan-Resiga D, Andreo U, et al
    Erratum for Essalmani et al., "Distinctive Roles of Furin and TMPRSS2 in SARS-CoV-2 Infectivity".
    J Virol. 2022 Jun 6:e0074522. doi: 10.1128/jvi.00745.
    >> Share

  29. CHEN X, Li J, Yang L, Zhou Y, et al
    Immunoglobin G Sero-Dynamics Aided Host Specific Linear Epitope Identification and Differentiation of Infected from Vaccinated Hosts.
    J Virol. 2022 Jun 6:e0014322. doi: 10.1128/jvi.00143.
    >> Share

  30. LIU H, Bai Y, Zhang X, Gao T, et al
    SARS-CoV-2 N Protein Antagonizes Stress Granule Assembly and IFN Production by Interacting with G3BPs to Facilitate Viral Replication.
    J Virol. 2022 Jun 2:e0041222. doi: 10.1128/jvi.00412.
    >> Share

    May 2022
  31. ZHAO J, Feng D, Zhao Y, Huang M, et al
    Role of Stress Granules in Suppressing Viral Replication by the Infectious Bronchitis Virus Endoribonuclease.
    J Virol. 2022 May 31:e0068622. doi: 10.1128/jvi.00686.
    >> Share

  32. DIJKMAN R, Verma AK, Selvaraj M, Ghimire R, et al
    Effective Interferon Lambda Treatment Regimen To Control Lethal MERS-CoV Infection in Mice.
    J Virol. 2022 May 19:e0036422. doi: 10.1128/jvi.00364.
    >> Share

  33. NIU X, Kong F, Xu J, Liu M, et al
    Mutations in Porcine Epidemic Diarrhea Virus nsp1 Cause Increased Viral Sensitivity to Host Interferon Responses and Attenuation In Vivo.
    J Virol. 2022 May 18:e0046922. doi: 10.1128/jvi.00469.
    >> Share

  34. NCHIOUA R, Schundner A, Kmiec D, Prelli Bozzo C, et al
    SARS-CoV-2 Variants of Concern Hijack IFITM2 for Efficient Replication in Human Lung Cells.
    J Virol. 2022 May 11:e0059422. doi: 10.1128/jvi.00594.
    >> Share

  35. DONG S, Kong N, Zhang Y, Li Y, et al
    TARDBP Inhibits Porcine Epidemic Diarrhea Virus Replication through Degrading Viral Nucleocapsid Protein and Activating Type I Interferon Signaling.
    J Virol. 2022 May 2:e0007022. doi: 10.1128/jvi.00070.
    >> Share

    April 2022
  36. ZHANG J, Yuan S, Peng Q, Ding Z, et al
    Porcine Epidemic Diarrhea Virus nsp7 Inhibits Interferon-Induced JAK-STAT Signaling through Sequestering the Interaction between KPNA1 and STAT1.
    J Virol. 2022 Apr 20:e0040022. doi: 10.1128/jvi.00400.
    >> Share

  37. LI J, Li Y, Liu P, Wang X, et al
    Porcine Epidemic Diarrhea Virus Infection Disrupts the Nasal Endothelial Barrier To Favor Viral Dissemination.
    J Virol. 2022 Apr 18:e0038022. doi: 10.1128/jvi.00380.
    >> Share

  38. ZHENG XS, Wang Q, Min J, Shen XR, et al
    Single-Cell Landscape of Lungs Reveals Key Role of Neutrophil-Mediated Immunopathology during Lethal SARS-CoV-2 Infection.
    J Virol. 2022 Apr 14:e0003822. doi: 10.1128/jvi.00038.
    >> Share

  39. AGUILAR EG, Paniccia G, Adura C, Singer ZS, et al
    Sindbis Macrodomain Poly-ADP-Ribose Hydrolase Activity Is Important for Viral RNA Synthesis.
    J Virol. 2022;96:e0151621.
    >> Share

  40. DESCHAMBAULT Y, Lynch J, Warner B, Tierney K, et al
    Single Immunization with Recombinant ACAM2000 Vaccinia Viruses Expressing the Spike and the Nucleocapsid Proteins Protects Hamsters against SARS-CoV-2-Caused Clinical Disease.
    J Virol. 2022 Apr 12:e0038922. doi: 10.1128/jvi.00389.
    >> Share

  41. LANGLEY WA, Wieland A, Ahmed H, Rasheed MAU, et al
    Persistence of Virus-Specific Antibody after Depletion of Memory B Cells.
    J Virol. 2022 Apr 11:e0002622. doi: 10.1128/jvi.00026.
    >> Share

  42. CHEN J, Li Z, Guo J, Xu S, et al
    SARS-CoV-2 nsp5 Exhibits Stronger Catalytic Activity and Interferon Antagonism than Its SARS-CoV Ortholog.
    J Virol. 2022 Apr 7:e0003722. doi: 10.1128/jvi.00037.
    >> Share

  43. FARIAS JP, da Silva PS, Fogaca MMC, Santana IVR, et al
    The COVID-19 Humoral Immunological Status Induced by CoronaVac and AstraZeneca Vaccines Significantly Benefits from a Booster Shot with the Pfizer Vaccine.
    J Virol. 2022 Apr 7:e0017722. doi: 10.1128/jvi.00177.
    >> Share

  44. LI J, Lin C, Zhou X, Zhong F, et al
    Structural Basis of the Main Proteases of Coronavirus Bound to Drug Candidate PF-07321332.
    J Virol. 2022 Apr 7:e0201321. doi: 10.1128/jvi.02013.
    >> Share

  45. KLASSE PJ, Moore JP
    Reappraising the Value of HIV-1 Vaccine Correlates of Protection Analyses.
    J Virol. 2022 Apr 6:e0003422. doi: 10.1128/jvi.00034.
    >> Share

    March 2022
  46. HANCOCK TJ, Hickman P, Kazerooni N, Kennedy M, et al
    Possible Cross-Reactivity of Feline and White-Tailed Deer Antibodies against the SARS-CoV-2 Receptor Binding Domain.
    J Virol. 2022 Mar 30:e0025022. doi: 10.1128/jvi.00250.
    >> Share

  47. ESSALMANI R, Jain J, Susan-Resiga D, Andreo U, et al
    Distinctive Roles of Furin and TMPRSS2 in SARS-CoV-2 Infectivity.
    J Virol. 2022 Mar 28:e0012822. doi: 10.1128/jvi.00128.
    >> Share

  48. GENG Q, Shi K, Ye G, Zhang W, et al
    Structural Basis for Human Receptor Recognition by SARS-CoV Omicron Variant BA.1.
    J Virol. 2022 Mar 28:e0024922. doi: 10.1128/jvi.00249.
    >> Share

  49. LIU MQ, Jiang RD, Guo J, Chen Y, et al
    Inactivated SARS-CoV-2 Vaccine Shows Cross-Protection against Bat SARS-Related Coronaviruses in Human ACE2 Transgenic Mice.
    J Virol. 2022 Mar 28:e0016922. doi: 10.1128/jvi.00169.
    >> Share

  50. XIANG J, Lu M, Shi M, Cheng X, et al
    Heparanase Blockade as a Novel Dual-Targeting Therapy for COVID-19.
    J Virol. 2022 Mar 23:e0005722. doi: 10.1128/jvi.00057.
    >> Share

  51. LIU X, Yin L, Xue M, Chen J, et al
    Coronavirus Porcine Deltacoronavirus Upregulates MHC Class I Expression through RIG-I/IRF1-Mediated NLRC5 Induction.
    J Virol. 2022 Mar 21:e0015822. doi: 10.1128/jvi.00158.
    >> Share

  52. REINECKE B, Frericks N, Lauber C, Dinkelborg K, et al
    The Human Liver-Expressed Lectin CD302 Restricts Hepatitis C Virus Infection.
    J Virol. 2022 Mar 17:e0199521. doi: 10.1128/jvi.01995.
    >> Share

  53. BERKHOUT B, Herrera-Carrillo E
    SARS-CoV-2 Evolution: On the Sudden Appearance of the Omicron Variant.
    J Virol. 2022 Mar 16:e0009022. doi: 10.1128/jvi.00090.
    >> Share

  54. GAO J, Tang YD, Hu W, Zheng C, et al
    When Poly(A) Binding Proteins Meet Viral Infections, Including SARS-CoV-2.
    J Virol. 2022 Mar 16:e0013622. doi: 10.1128/jvi.00136.
    >> Share

  55. METZ-ZUMARAN C, Kee C, Doldan P, Guo C, et al
    Increased Sensitivity of SARS-CoV-2 to Type III Interferon in Human Intestinal Epithelial Cells.
    J Virol. 2022 Mar 9:e0170521. doi: 10.1128/jvi.01705.
    >> Share

  56. LI M, Wu Y, Chen J, Shi H, et al
    Innate Immune Evasion of Porcine Epidemic Diarrhea Virus through Degradation of the FBXW7 Protein via the Ubiquitin-Proteasome Pathway.
    J Virol. 2022;96:e0088921.
    >> Share

    February 2022
  57. JUNG C, Kmiec D, Koepke L, Zech F, et al
    Omicron: what makes the latest SARS-CoV-2 variant of concern so concerning?
    J Virol. 2022 Feb 28:jvi0207721. doi: 10.1128/jvi.02077.
    >> Share

  58. KIM EH, Nguyen TQ, Casel MAB, Rollon R, et al
    Coinfection of SARS-CoV-2 and Influenza A virus increased disease severity, impaired neutralizing antibody, and CD4+ T cell responses.
    J Virol. 2022 Feb 2:jvi0187321. doi: 10.1128/jvi.01873.
    >> Share

  59. ARIUMI Y
    Host cellular RNA helicases regulate SARS-CoV-2 infection.
    J Virol. 2022 Feb 2:jvi0000222. doi: 10.1128/jvi.00002.
    >> Share

    January 2022
  60. LIU S, Chou CK, Wu WW, Luan B, et al
    Stable Cell Clones Harboring Self-Replicating SARS-CoV-2 RNAs for Drug Screen.
    J Virol. 2022 Jan 26:jvi0221621. doi: 10.1128/jvi.02216.
    >> Share

  61. WONG TY, Horspool AM, Russ BP, Ye C, et al
    Evaluating antibody mediated protection against Alpha, Beta, and Delta SARS-CoV-2 variants of concern in K18-hACE2 transgenic mice.
    J Virol. 2022 Jan 26:jvi0218421. doi: 10.1128/jvi.02184.
    >> Share

  62. CHEN W, Huang C, Shi Y, Li N, et al
    Investigation of the Crosstalk between GRP78/PERK/ATF-4 Signaling Pathway and Renal Apoptosis Induced by Nephropathogenic Infectious Bronchitis Virus Infection.
    J Virol. 2022;96:e0142921.
    >> Share

  63. DU S, Xu W, Wang Y, Li L, et al
    The "LLQY" motif on SARS-CoV-2 spike protein affects S incorporation into virus particles.
    J Virol. 2022 Jan 19:jvi0189721. doi: 10.1128/jvi.01897.
    >> Share

  64. KEEP S, Stevenson-Leggett P, Dowgier G, Everest H, et al
    Identification of amino acids within non-structural proteins 10 and 14 of the avian coronavirus infectious bronchitis virus that result in attenuation in vivo and in ovo.
    J Virol. 2022 Jan 19:jvi0205921. doi: 10.1128/jvi.02059.
    >> Share

  65. CHAUDHRY MZ, Eschke K, Hoffmann M, Grashoff M, et al
    Rapid SARS-CoV-2 Adaptation to Available Cellular Proteases.
    J Virol. 2022 Jan 12:jvi0218621. doi: 10.1128/jvi.02186.
    >> Share


  66. Articles of Significant Interest in This Issue.
    J Virol. 2022;96:e0186421.
    >> Share

  67. LI S, Liu S, Chen RA, Huang M, et al
    Activation of the MKK3-p38-MK2-ZFP36 axis by coronavirus infection restricts the upregulation of AU-rich element-containing transcripts in proinflammatory response.
    J Virol. 2022 Jan 5:jvi0208621. doi: 10.1128/jvi.02086.
    >> Share

    December 2021
  68. HUANG Y, Skarlupka AL, Jang H, Blas-Machado U, et al
    SARS-CoV-2 and Influenza A virus Co-infections in Ferrets.
    J Virol. 2021 Dec 22:JVI0179121. doi: 10.1128/JVI.01791.
    >> Share

  69. OLIVARRIA GM, Cheng Y, Furman S, Pachow C, et al
    Microglia do not restrict SARS-CoV-2 replication following infection of the central nervous system of K18-hACE2 transgenic mice.
    J Virol. 2021 Dec 22:jvi0196921. doi: 10.1128/jvi.01969.
    >> Share

  70. ETTICH J, Werner J, Weitz HT, Mueller E, et al
    A hybrid soluble gp130/spike-nanobody fusion protein simultaneously blocks IL-6 trans-signaling and cellular infection with SARS-CoV2.
    J Virol. 2021 Dec 22:JVI0162221. doi: 10.1128/JVI.01622.
    >> Share

  71. NELSON M, O'Brien LM, Davies C, Keyser E, et al
    Comparison of experimental MERS-CoV infection acquired by three individual routes of infection in the common marmoset.
    J Virol. 2021 Dec 15:JVI0173921. doi: 10.1128/JVI.01739.
    >> Share

  72. CAO K, Wang X, Peng H, Ding L, et al
    A Single Vaccine Protects against SARS-CoV-2 and Influenza Virus in Mice.
    J Virol. 2021 Dec 15:JVI0157821. doi: 10.1128/JVI.01578.
    >> Share

  73. SHI J, Shi Y, Xiu R, Wang G, et al
    Identification of a novel neutralizing epitope on the N-terminal domain of the HCoV-229E spike protein.
    J Virol. 2021 Dec 15:JVI0195521. doi: 10.1128/JVI.01955.
    >> Share

  74. ZHANG Y, Yan Q, Luo K, He P, et al
    Analysis of B cell receptor repertoires reveals key signatures of systemic B cell response after SARS-CoV-2 infection.
    J Virol. 2021 Dec 8:JVI0160021. doi: 10.1128/JVI.01600.
    >> Share

  75. MALICOAT J, Manivasagam S, Zuniga S, Sola I, et al
    Development of a Single-cycle Infectious SARS-CoV-2 Virus Replicon Particle System for use in BSL2 Laboratories.
    J Virol. 2021 Dec 1:JVI0183721. doi: 10.1128/JVI.01837.
    >> Share

    November 2021
  76. TAKAMATSU Y, Imai M, Maeda K, Nakajima N, et al
    Highly Neutralizing COVID-19 Convalescent Plasmas Potently Block SARS-CoV-2 Replication and Pneumonia in Syrian Hamsters.
    J Virol. 2021 Nov 24:JVI0155121. doi: 10.1128/JVI.01551.
    >> Share

  77. ZHANG S, Go EP, Ding H, Anang S, et al
    Glycosylation and disulfide bonding of wild-type SARS-CoV-2 spike glycoprotein.
    J Virol. 2021 Nov 24:JVI0162621. doi: 10.1128/JVI.01626.
    >> Share

  78. UJIKE M, Etoh Y, Urushiyama N, Taguchi F, et al
    Reverse Genetics with a Full-length Infectious cDNA Clone of Bovine Torovirus.
    J Virol. 2021 Nov 24:JVI0156121. doi: 10.1128/JVI.01561.
    >> Share

  79. MARTINS M, Fernandes MHV, Joshi LR, Diel DG, et al
    Age-related susceptibility of ferrets to SARS-CoV-2 infection.
    J Virol. 2021 Nov 24:JVI0145521. doi: 10.1128/JVI.01455.
    >> Share

  80. BURCKHARDT RM, Dennehy JJ, Poon LLM, Saif LJ, et al
    Are COVID-19 Vaccine Boosters Needed? The Science behind Boosters.
    J Virol. 2021 Nov 24:JVI0197321. doi: 10.1128/JVI.01973.
    >> Share

  81. LI Y, Jin Y, Kuang L, Luo Z, et al
    The N-terminal Region of Middle East Respiratory Syndrome Coronavirus Accessory Protein 8b is Essential for Enhanced Virulence of an Attenuated Murine Coronavirus.
    J Virol. 2021 Nov 24:JVI0184221. doi: 10.1128/JVI.01842.
    >> Share

  82. LIU Y, Wang B, Liang QZ, Shi FS, et al
    Roles of Two Major Domains of the Porcine Deltacoronavirus S1 Subunit in Receptor Binding and Neutralization.
    J Virol. 2021;95:e0111821.
    >> Share

  83. HEMSATH JR, Liaci AM, Rubin JD, Parrett BJ, et al
    Ex Vivo and In Vivo CD46 Receptor Utilization by Species D Human Adenovirus Serotype 26 (HAdV26).
    J Virol. 2021 Nov 17:JVI0082621. doi: 10.1128/JVI.00826.
    >> Share

  84. BASU A, Penumutchu S, Nguyen K, Mbonye U, et al
    A structurally conserved RNA element within SARS-CoV-2 ORF1a RNA and S mRNA regulates translation in response to viral S protein-induced signaling in human lung cells.
    J Virol. 2021 Nov 10:JVI0167821. doi: 10.1128/JVI.01678.
    >> Share

  85. LAMARCA AP, de Almeida LGP, da Silva Francisco Junior R, Cavalcante L, et al
    Genomic Surveillance Tracks the First Community Outbreak of the SARS-CoV-2 Delta (B.1.617.2) Variant in Brazil.
    J Virol. 2021 Nov 3:JVI0122821. doi: 10.1128/JVI.01228.
    >> Share

    October 2021
  86. YU J, Collins ND, Mercado NB, McMahan K, et al
    Protective Efficacy of Gastrointestinal SARS-CoV-2 Delivery Against Intranasal and Intratracheal SARS-CoV-2 Challenge in Rhesus Macaques.
    J Virol. 2021 Oct 27:JVI0159921. doi: 10.1128/JVI.01599.
    >> Share

  87. SHARMA L, Peng X, Qing H, Hilliard BK, et al
    Distinct Roles of Type I and Type III Interferons During a Native Murine beta Coronavirus Lung Infection.
    J Virol. 2021 Oct 27:JVI0124121. doi: 10.1128/JVI.01241.
    >> Share

  88. YAN B, Chakravorty S, Mirabelli C, Wang L, et al
    Reply to Grigoriev et al., "Sequences of SARS-CoV-2 "Hybrids" with the Human Genome: Signs 1 of Non-coding RNA?"
    J Virol. 2021 Oct 27:JVI0169021. doi: 10.1128/JVI.01690.
    >> Share

  89. GRIGORIEV A, Kelley JJ, Guan L
    Sequences of SARS-CoV-2 "Hybrids" with the Human Genome: Signs of Non-coding RNA?
    J Virol. 2021 Oct 27:JVI0146221. doi: 10.1128/JVI.01462.
    >> Share

  90. SIDDIQ MM, Chan AT, Miorin L, Yadaw AS, et al
    Functional Effects of Cardiomyocyte Injury in COVID-19.
    J Virol. 2021 Oct 20:JVI0106321. doi: 10.1128/JVI.01063.
    >> Share

  91. WINKLER ES, Chen RE, Alam F, Yildiz S, et al
    SARS-CoV-2 causes lung infection without severe disease in human ACE2 knock-in mice.
    J Virol. 2021 Oct 20:JVI0151121. doi: 10.1128/JVI.01511.
    >> Share

  92. DONG W, Mead H, Tian L, Park JG, et al
    The K18-hACE2 Transgenic Mouse Model Recapitulates Non-Severe and Severe COVID-19 in Response to Infectious Dose of SARS-CoV-2 Virus.
    J Virol. 2021 Oct 20:JVI0096421. doi: 10.1128/JVI.00964.
    >> Share

  93. LUSVARGHI S, Wang W, Herrup R, Neerukonda SN, et al
    Key substitutions in the spike protein of SARS-CoV-2 variants can predict resistance to monoclonal antibodies, but other substitutions can modify the effects.
    J Virol. 2021 Oct 20:JVI0111021. doi: 10.1128/JVI.01110.
    >> Share

  94. REN W, Zhu Y, Lan J, Chen H, et al
    Susceptibilities of human ACE2 genetic variants in coronavirus infection.
    J Virol. 2021 Oct 20:JVI0149221. doi: 10.1128/JVI.01492.
    >> Share

  95. CHU HF, Cheng SC, Sun CY, Chou CY, et al
    Structural and Biochemical Characterization of PEDV Papain-like Protease 2.
    J Virol. 2021 Oct 13:JVI0137221. doi: 10.1128/JVI.01372.
    >> Share

  96. SHI J, Li Z, Xu R, Zhang J, et al
    The PERK/PKR-eIF2alpha pathway negatively regulates porcine hemagglutinating encephalomyelitis virus replication by attenuating global protein translation and facilitating stress granule formation.
    J Virol. 2021 Oct 13:JVI0169521. doi: 10.1128/JVI.01695.
    >> Share

  97. NAVARATNARAJAH CK, Pease DR, Halfmann P, Taye B, et al
    Highly efficient SARS-CoV-2 infection of human cardiomyocytes: spike protein-mediated cell fusion and its inhibition.
    J Virol. 2021 Oct 6:JVI0136821. doi: 10.1128/JVI.01368.
    >> Share

    September 2021
  98. SHUE B, Chiramel AI, Cerikan B, To TH, et al
    Genome-wide CRISPR screen identifies RACK1 as a critical host factor for flavivirus replication.
    J Virol. 2021 Sep 29:JVI0059621. doi: 10.1128/JVI.00596.
    >> Share

  99. SIEGERS JY, Dhanasekaran V, Xie R, Deng YM, et al
    Genetic and Antigenic Characterization of an Influenza A(H3N2) Outbreak in Cambodia and the Greater Mekong Subregion during the COVID-19 Pandemic, 2020.
    J Virol. 2021 Sep 29:JVI0126721. doi: 10.1128/JVI.01267.
    >> Share

  100. KIM YJ, Witwit H, Cubitt B, de la Torre JC, et al
    Inhibitors of anti-apoptotic Bcl-2 family proteins exhibit potent and broad-spectrum anti-mammarenavirus activity via cell cycle arrest at G0/G1 phase.
    J Virol. 2021 Sep 29:JVI0139921. doi: 10.1128/JVI.01399.
    >> Share

  101. FANG P, Zhang J, Zhang H, Xia S, et al
    Porcine deltacoronavirus enters porcine IPI-2I intestinal epithelial cells via macropinocytosis and clathrin-mediated endocytosis dependent on pH and dynamin.
    J Virol. 2021 Sep 29:JVI0134521. doi: 10.1128/JVI.01345.
    >> Share

  102. ZHANG Y, Gao H, Hu X, Wang Q, et al
    Structure-based discovery and structural basis of a novel broad-spectrum natural product against main protease of coronavirus.
    J Virol. 2021 Sep 29:JVI0125321. doi: 10.1128/JVI.01253.
    >> Share

  103. PELZ L, Rudiger D, Dogra T, Alnaji FG, et al
    Semi-continuous propagation of influenza A virus and its defective interfering particles: analyzing the dynamic competition to select candidates for antiviral therapy.
    J Virol. 2021 Sep 22:JVI0117421. doi: 10.1128/JVI.01174.
    >> Share

  104. ACHARYA A, Pandey K, Thurman M, Klug E, et al
    Discovery and evaluation of entry inhibitors for SARS-CoV-2 and its emerging variants.
    J Virol. 2021 Sep 22:JVI0143721. doi: 10.1128/JVI.01437.
    >> Share

  105. SHANG C, Zhuang X, Zhang H, Li Y, et al
    Inhibition of autophagy suppresses SARS-CoV-2 replication and ameliorates pneumonia in hACE2 transgenic mice and xenografted human lung tissues.
    J Virol. 2021 Sep 22:JVI0153721. doi: 10.1128/JVI.01537.
    >> Share

  106. QIAN Y, Lei T, Patel PS, Lee CH, et al
    Direct activation of endothelial cells by SARS-CoV-2 nucleocapsid protein is blocked by Simvastatin.
    J Virol. 2021 Sep 22:JVI0139621. doi: 10.1128/JVI.01396.
    >> Share

  107. CHOI A, Koch M, Wu K, Dixon G, et al
    Serum Neutralizing Activity of mRNA-1273 Against SARS-CoV-2 Variants.
    J Virol. 2021 Sep 22:JVI0131321. doi: 10.1128/JVI.01313.
    >> Share

  108. TOSTANOSKI LH, Gralinski LE, Martinez DR, Schaefer A, et al
    Protective efficacy of rhesus adenovirus COVID-19 vaccines against mouse-adapted SARS-CoV-2.
    J Virol. 2021 Sep 15:JVI0097421. doi: 10.1128/JVI.00974.
    >> Share

  109. NILSSON-PAYANT BE, Uhl S, Grimont A, Doane AS, et al
    The NF-kappaB transcriptional footprint is essential for SARS-CoV-2 replication.
    J Virol. 2021 Sep 15:JVI0125721. doi: 10.1128/JVI.01257.
    >> Share

  110. CHEN HY, Huang C, Tian L, Huang X, et al
    Cytoplasmic tail truncation of SARS-CoV-2 Spike protein enhances titer of pseudotyped vectors but masks the effect of the D614G mutation.
    J Virol. 2021 Sep 8:JVI0096621. doi: 10.1128/JVI.00966.
    >> Share

  111. CHIEM K, Morales Vasquez D, Silvas JA, Park JG, et al
    A bifluorescent-based assay for the identification of neutralizing antibodies against SARS-CoV-2 variants of concern in vitro and in vivo.
    J Virol. 2021 Sep 8:JVI0112621. doi: 10.1128/JVI.01126.
    >> Share

  112. ANDRADE ACDSP, Gabriel Campolina-Silva H, Queiroz-Junior CM, de Oliveira LC, et al
    A biosafety level-2 mouse model for studying betacoronavirus-induced acute lung damage and systemic manifestations.
    J Virol. 2021 Sep 8:JVI0127621. doi: 10.1128/JVI.01276.
    >> Share

    August 2021
  113. LI X, Wang L, Liu P, Li H, et al
    A novel potentially recombinant rodent coronavirus with a polybasic cleavage site in the spike protein.
    J Virol. 2021 Aug 25:JVI0117321. doi: 10.1128/JVI.01173.
    >> Share

  114. SHILIAEV N, Lukash T, Palchevska O, Crossman DK, et al
    Natural isolate and recombinant SARS-CoV-2 rapidly evolve in vitro to higher infectivity through more efficient binding to heparan sulfate and reduced S1/S2 cleavage.
    J Virol. 2021 Aug 18:JVI0135721. doi: 10.1128/JVI.01357.
    >> Share

  115. YANG YL, Liu J, Wang TY, Chen M, et al
    Aminopeptidase N is an entry co-factor triggering porcine deltacoronavirus entry via an endocytotic pathway.
    J Virol. 2021 Aug 18:JVI0094421. doi: 10.1128/JVI.00944.
    >> Share

  116. WANG G, Hu G, Liang R, Shi J, et al
    Establishment of Full-length cDNA Clones and an Efficient Oral Infection Model for Feline Coronavirus in Cats.
    J Virol. 2021 Aug 18:JVI0074521. doi: 10.1128/JVI.00745.
    >> Share

  117. KREUTZBERGER AJB, Sanyal A, Ojha R, Pyle JD, et al
    Synergistic block of SARS-CoV-2 infection by combined drug inhibition of the host entry factors PIKfyve kinase and TMPRSS2 protease.
    J Virol. 2021 Aug 18:JVI0097521. doi: 10.1128/JVI.00975.
    >> Share

  118. LU M, Zhang Y, Dravid P, Li A, et al
    A methyltransferase-defective VSV-based SARS-CoV-2 vaccine candidate provides complete protection against SARS-CoV-2 infection in hamsters.
    J Virol. 2021 Aug 11:JVI0059221. doi: 10.1128/JVI.00592.
    >> Share

    July 2021
  119. CANTWELL AM, Singh H, Platt M, Yu Y, et al
    Kinetic multi-omic analysis of responses to SARS-CoV-2 infection in a model of severe COVID-19.
    J Virol. 2021 Jul 28:JVI0101021. doi: 10.1128/JVI.01010.
    >> Share

  120. LI Z, Gao F, Lan Y, Guan J, et al
    Porcine Haemagglutinating Encephalomyelitis Virus Triggers Neural Autophagy Independent of ULK1.
    J Virol. 2021 Jul 21:JVI0085121. doi: 10.1128/JVI.00851.
    >> Share

  121. WANG H, Kong N, Jiao Y, Dong S, et al
    EGR1 suppresses porcine epidemic diarrhea virus replication by regulating IRAV to degrade viral nucleocapsid protein.
    J Virol. 2021 Jul 21:JVI0064521. doi: 10.1128/JVI.00645.
    >> Share

  122. FERRARI M, Mekkaoui L, Ilca FT, Akbar Z, et al
    Characterisation of a novel ACE2-based therapeutic with enhanced rather than reduced activity against SARS-CoV-2 variants.
    J Virol. 2021 Jul 21:JVI0068521. doi: 10.1128/JVI.00685.
    >> Share

  123. CHEN DY, Khan N, Close BJ, Goel RK, et al
    SARS-CoV-2 disrupts proximal elements in the JAK-STAT pathway.
    J Virol. 2021 Jul 14:JVI0086221. doi: 10.1128/JVI.00862.
    >> Share

  124. XU J, Mao J, Han X, Shi F, et al
    Porcine epidemic diarrhea virus inhibits HDAC1 expression to facilitate its replication via binding of its nucleocapsid protein to host transcription factor Sp1.
    J Virol. 2021 Jul 7:JVI0085321. doi: 10.1128/JVI.00853.
    >> Share

    June 2021
  125. NGUYEN HT, Falzarano D, Gerdts V, Liu Q, et al
    Construction of a non-infectious SARS-CoV-2 replicon for antiviral drug testing and gene function studies.
    J Virol. 2021 Jun 30:JVI0068721. doi: 10.1128/JVI.00687.
    >> Share

  126. SUN G, Sui Y, Zhou Y, Ya J, et al
    Structural basis of covalent inhibitory mechanism of TMPRSS2-related serine proteases by camostat.
    J Virol. 2021 Jun 23:JVI0086121. doi: 10.1128/JVI.00861.
    >> Share

  127. MEYER K, Patra T, Vijayamahantesh, Ray R, et al
    SARS-CoV-2 spike protein induces paracrine senescence and leukocyte adhesionin endothelial cells.
    J Virol. 2021 Jun 23:JVI0079421. doi: 10.1128/JVI.00794.
    >> Share

  128. SILVAS JA, Morales Vasquez D, Park JG, Chiem K, et al
    Contribution of SARS-CoV-2 accessory proteins to viral pathogenicity in K18 hACE2 transgenic mice.
    J Virol. 2021 Jun 16:JVI0040221. doi: 10.1128/JVI.00402.
    >> Share

  129. LI A, Zhao K, Zhang B, Hua R, et al
    SARS-CoV-2 NSP12 protein is not an IFN-beta antagonist.
    J Virol. 2021 Jun 16:JVI0074721. doi: 10.1128/JVI.00747.
    >> Share

  130. KUMAR A, Ishida R, Strilets T, Cole J, et al
    SARS-CoV-2 Nonstructural Protein 1 Inhibits the Interferon Response by Causing Depletion of Key Host Signaling Factors.
    J Virol. 2021;95:e0026621.
    >> Share

  131. HAYASHI Y, Tsuchiya K, Yamamoto M, Nemoto-Sasaki Y, et al
    N-(4-Hydroxyphenyl) retinamide suppresses SARS-CoV-2 spike protein-mediated cell-cell fusion by a dihydroceramide Delta4-desaturase 1-independent mechanism.
    J Virol. 2021 Jun 9:JVI0080721. doi: 10.1128/JVI.00807.
    >> Share

  132. WANG X, Zhao Y, Yan F, Wang T, et al
    Viral and host transcriptomes in SARS-CoV-2 infected human lung cells.
    J Virol. 2021 Jun 9:JVI0060021. doi: 10.1128/JVI.00600.
    >> Share

  133. QIN Y, Tu K, Teng Q, Feng D, et al
    Identification of novel T-cell epitopes on infectious bronchitis virus N protein and development of a multi-epitope vaccine.
    J Virol. 2021 Jun 9:JVI0066721. doi: 10.1128/JVI.00667.
    >> Share

  134. OU J, Zhou Z, Dai R, Zhang J, et al
    V367F mutation in SARS-CoV-2 spike RBD emerging during the early transmission phase enhances viral infectivity through increased human ACE2 receptor binding affinity.
    J Virol. 2021 Jun 2:JVI0061721. doi: 10.1128/JVI.00617.
    >> Share

    May 2021
  135. SU M, Shi D, Xing X, Qi S, et al
    Coronavirus PEDV nucleocapsid protein interacts with p53 to induce cell cycle arrest in S-phase and promotes viral replication.
    J Virol. 2021 May 26:JVI0018721. doi: 10.1128/JVI.00187.
    >> Share

  136. LATOURRETTE K, Holste NM, Rodriguez-Pena R, Leme RA, et al
    Genome-wide variation in betacoronaviruses.
    J Virol. 2021 May 26:JVI0049621. doi: 10.1128/JVI.00496.
    >> Share

  137. DOSTALIK P, Krafcikova P, Silhan J, Kozic J, et al
    Structural analysis of the OC43 coronavirus 2'-O-RNA methyltransferase.
    J Virol. 2021 May 19. pii: JVI.00463-21. doi: 10.1128/JVI.00463.
    >> Share

  138. VOTH LS, O'Connor JJ, Kerr CM, Doerger E, et al
    Unique mutations in the MHV macrodomain differentially attenuate virus replication, indicating multiple roles for the macrodomain in coronavirus replication.
    J Virol. 2021 May 19. pii: JVI.00766-21. doi: 10.1128/JVI.00766.
    >> Share

  139. YAN B, Chakravorty S, Mirabelli C, Wang L, et al
    Host-virus chimeric events in SARS-CoV2 infected cells are infrequent and artifactual.
    J Virol. 2021 May 12. pii: JVI.00294-21. doi: 10.1128/JVI.00294.
    >> Share

  140. CARNELL GW, Ciazynska KA, Wells DA, Xiong X, et al
    SARS-CoV-2 spike protein stabilized in the closed state induces potent neutralizing responses.
    J Virol. 2021 May 7. pii: JVI.00203-21. doi: 10.1128/JVI.00203.
    >> Share

  141. TRIBOLET L, Alexander MR, Brice AM, van Vuren PJ, et al
    ILRUN downregulates ACE2 expression and blocks infection of human cells by SARS-CoV-2.
    J Virol. 2021 May 7. pii: JVI.00327-21. doi: 10.1128/JVI.00327.
    >> Share

  142. LULLA V, Wandel MP, Bandyra KJ, Ulferts R, et al
    Targeting the conserved stem loop 2 motif in the SARS-CoV-2 genome.
    J Virol. 2021 May 7. pii: JVI.00663-21. doi: 10.1128/JVI.00663.
    >> Share

  143. LEE W, Kingstad-Bakke B, Kedl RM, Kawaoka Y, et al
    CCR2 Regulates Vaccine-Induced Mucosal T-Cell Memory to Influenza A Virus.
    J Virol. 2021 May 5. pii: JVI.00530-21. doi: 10.1128/JVI.00530.
    >> Share

    April 2021
  144. RESNICK SJ, Iketani S, Hong SJ, Zask A, et al
    Inhibitors of coronavirus 3CL proteases protect cells from protease-mediated cytotoxicity.
    J Virol. 2021 Apr 28. pii: JVI.02374-20. doi: 10.1128/JVI.02374.
    >> Share

  145. ALFI O, Yakirevitch A, Wald O, Wandel O, et al
    Human nasal and lung tissues infected ex vivo with SARS-CoV-2 provide insights into differential tissue-specific and virus-specific innate immune responses in the upper and lower respiratory tract.
    J Virol. 2021 Apr 23. pii: JVI.00130-21. doi: 10.1128/JVI.00130.
    >> Share

  146. VIDAL SJ, Collier AY, Yu J, McMahan K, et al
    Correlates of Neutralization Against SARS-CoV-2 Variants of Concern by Early Pandemic Sera.
    J Virol. 2021 Apr 23. pii: JVI.00404-21. doi: 10.1128/JVI.00404.
    >> Share

  147. VERMA D, Mel Church T, Swaminathan S
    Epstein-Barr virus lytic replication induces ACE2 expression and enhances SARS CoV-2 pseudotyped virus entry in epithelial cells.
    J Virol. 2021 Apr 14. pii: JVI.00192-21. doi: 10.1128/JVI.00192.
    >> Share

  148. PATEL DR, Field CJ, Septer KM, Sim DG, et al
    Transmission and protection against re-infection in the ferret model with the SARS-CoV-2 USA-WA1/2020 reference isolate.
    J Virol. 2021 Apr 7. pii: JVI.02232-20. doi: 10.1128/JVI.02232.
    >> Share

    March 2021
  149. LIU W, Reyes HM, Yang JF, Li Y, et al
    Activation of STING signaling pathway effectively blocks human coronavirus infection.
    J Virol. 2021 Mar 31. pii: JVI.00490-21. doi: 10.1128/JVI.00490.
    >> Share

  150. TOMITA Y, Matsuyama S, Fukuhara H, Maenaka K, et al
    The physiological TMPRSS2 inhibitor HAI-2 alleviates SARS-CoV-2 infection.
    J Virol. 2021 Mar 31. pii: JVI.00434-21. doi: 10.1128/JVI.00434.
    >> Share

  151. MORA-DIAZ JC, Pineyro PE, Rauh R, Nelson W, et al
    Porcine hemagglutinating encephalomyelitis virus infection in vivo and ex vivo.
    J Virol. 2021 Mar 24. pii: JVI.02335-20. doi: 10.1128/JVI.02335.
    >> Share

  152. YU J, Li Z, He X, Gebre MS, et al
    Deletion of the SARS-CoV-2 Spike Cytoplasmic Tail Increases Infectivity in Pseudovirus Neutralization Assays.
    J Virol. 2021 Mar 16. pii: JVI.00044-21. doi: 10.1128/JVI.00044.
    >> Share

  153. CHENG J, Zhao Y, Hu Y, Zhao J, et al
    The furin-S2' site in avian coronavirus plays a key role in central nervous system damage progression.
    J Virol. 2021 Mar 16. pii: JVI.02447-20. doi: 10.1128/JVI.02447.
    >> Share

  154. MA J, Su D, Sun Y, Huang X, et al
    Cryo-EM structure of S-Trimer, a subunit vaccine candidate for COVID-19.
    J Virol. 2021 Mar 10. pii: JVI.00194-21. doi: 10.1128/JVI.00194.
    >> Share

  155. ZHANG Y, Huang K, Wang T, Deng F, et al
    SARS-CoV-2 rapidly adapts in aged BALB/c mice and induces typical pneumonia.
    J Virol. 2021 Mar 10. pii: JVI.02477-20. doi: 10.1128/JVI.02477.
    >> Share

  156. PALMER MV, Martins M, Falkenberg S, Buckley A, et al
    Susceptibility of white-tailed deer (Odocoileus virginianus) to SARS-CoV-2.
    J Virol. 2021 Mar 10. pii: JVI.00083-21. doi: 10.1128/JVI.00083.
    >> Share

  157. JACOB-DOLAN C, Feldman J, McMahan K, Yu J, et al
    Coronavirus-Specific Antibody Cross Reactivity in Rhesus Macaques Following SARS-CoV-2 Vaccination and Infection.
    J Virol. 2021 Mar 10. pii: JVI.00117-21. doi: 10.1128/JVI.00117.
    >> Share

  158. LIU S, Selvaraj P, Lien CZ, Nunez IA, et al
    The PRRA insert at the S1/S2 site modulates cellular tropism of SARS-CoV-2 and ACE2 usage by the closely related Bat RaTG13.
    J Virol. 2021 Mar 8. pii: JVI.01751-20. doi: 10.1128/JVI.01751.
    >> Share

  159. MA H, Zeng W, Meng X, Huang X, et al
    Potent Neutralization of SARS-CoV-2 by Hetero-bivalent Alpaca Nanobodies Targeting the Spike Receptor-Binding Domain.
    J Virol. 2021 Mar 3. pii: JVI.02438-20. doi: 10.1128/JVI.02438.
    >> Share

  160. VOLOCH CM, da Silva Francisco R Jr, de Almeida LGP, Cardoso CC, et al
    Genomic characterization of a novel SARS-CoV-2 lineage from Rio de Janeiro, Brazil.
    J Virol. 2021 Mar 1. pii: JVI.00119-21. doi: 10.1128/JVI.00119.
    >> Share

    February 2021
  161. DEINHARDT-EMMER S, Bottcher S, Haring C, Giebeler L, et al
    SARS-CoV-2 causes severe epithelial inflammation and barrier dysfunction.
    J Virol. 2021 Feb 26. pii: JVI.00110-21. doi: 10.1128/JVI.00110.
    >> Share

  162. LE COUPANEC A, Desforges M, Kaufer B, Dubeau P, et al
    Potential differences in cleavage of the S protein and type-1 interferon together control human coronavirus infection, propagation, and neuropathology within the central nervous system.
    J Virol. 2021 Feb 24. pii: JVI.00140-21. doi: 10.1128/JVI.00140.
    >> Share

  163. DHAKAL S, Loube J, Misplon JA, Lo CY, et al
    Effect of an adenovirus-vectored universal influenza virus vaccine on pulmonary pathophysiology in a mouse model.
    J Virol. 2021 Feb 24. pii: JVI.02359-20. doi: 10.1128/JVI.02359.
    >> Share

  164. DE VRIES M, Mohamed AS, Prescott RA, Valero-Jimenez AM, et al
    A comparative analysis of SARS-CoV-2 antivirals characterizes 3CL(pro) inhibitor PF-00835231 as a potential new treatment for COVID-19.
    J Virol. 2021 Feb 23. pii: JVI.01819-20. doi: 10.1128/JVI.01819.
    >> Share

  165. HORNICH BF, Grosskopf AK, Schlagowski S, Tenbusch M, et al
    SARS-CoV-2 and SARS-CoV spike-mediated cell-cell fusion differ in the requirements for receptor expression and proteolytic activation.
    J Virol. 2021 Feb 19. pii: JVI.00002-21. doi: 10.1128/JVI.00002.
    >> Share

  166. SUN L, Chen H, Ming X, Bo Z, et al
    Porcine Epidemic Diarrhea Virus Infection Induces Caspase-8 mediated G3BP1 Cleavage and Subverts Stress Granules to Promote Viral Replication.
    J Virol. 2021 Feb 10. pii: JVI.02344-20. doi: 10.1128/JVI.02344.
    >> Share

  167. WINSTONE H, Lista MJ, Reid AC, Bouton C, et al
    The polybasic cleavage site in the SARS-CoV-2 spike modulates viral sensitivity to Type I interferon and IFITM2.
    J Virol. 2021 Feb 9. pii: JVI.02422-20. doi: 10.1128/JVI.02422.
    >> Share

    January 2021
  168. REBENDENNE A, Valadao ALC, Tauziet M, Maarifi G, et al
    SARS-CoV-2 triggers an MDA-5-dependent interferon response which is unable to control replication in lung epithelial cells.
    J Virol. 2021 Jan 29. pii: JVI.02415-20. doi: 10.1128/JVI.02415.
    >> Share

  169. DAGOTTO G, Mercado NB, Martinez DR, Hou YJ, et al
    Comparison of Subgenomic and Total RNA in SARS-CoV-2 Challenged Rhesus Macaques.
    J Virol. 2021 Jan 20. pii: JVI.02370-20. doi: 10.1128/JVI.02370.
    >> Share

  170. DOMINGO E, Perales C
    The time for COVID-19 vaccination.
    J Virol. 2021 Jan 19. pii: JVI.02437-20. doi: 10.1128/JVI.02437.
    >> Share

  171. CHEN JS, Alfajaro MM, Chow RD, Wei J, et al
    Non-steroidal anti-inflammatory drugs dampen the cytokine and antibody response to SARS-CoV-2 infection.
    J Virol. 2021 Jan 13. pii: JVI.00014-21. doi: 10.1128/JVI.00014.
    >> Share

  172. CHIEM K, Morales Vasquez D, Park JG, Platt RN, et al
    Generation and Characterization of recombinant SARS-CoV-2 expressing reporter genes.
    J Virol. 2021 Jan 11. pii: JVI.02209-20. doi: 10.1128/JVI.02209.
    >> Share

  173. SHI Y, Shi J, Sun L, Tan Y, et al
    Insight into vaccine development for Alpha-coronaviruses based on structural and immunological analyses of spike proteins.
    J Virol. 2021 Jan 7. pii: JVI.02284-20. doi: 10.1128/JVI.02284.
    >> Share

  174. GARCIA-ARRIAZA J, Garaigorta U, Perez P, Lazaro-Frias A, et al
    COVID-19 vaccine candidates based on modified vaccinia virus Ankara expressing the SARS-CoV-2 spike induce robust T- and B-cell immune responses and full efficacy in mice.
    J Virol. 2021 Jan 7. pii: JVI.02260-20. doi: 10.1128/JVI.02260.
    >> Share

    December 2020
  175. ZHAO J, Sun L, Zhao Y, Feng D, et al
    Coronavirus Endoribonuclease Ensures Efficient Viral Replication and Prevents Protein Kinase R Activation.
    J Virol. 2020 Dec 23. pii: JVI.02103-20. doi: 10.1128/JVI.02103.
    >> Share

  176. LEE E, Sandgren K, Duette G, Stylianou VV, et al
    Identification of SARS-CoV-2 Nucleocapsid and Spike T-cell Epitopes for Assessing T-cell Immunity.
    J Virol. 2020 Dec 21. pii: JVI.02002-20. doi: 10.1128/JVI.02002.
    >> Share

  177. NGUYEN HT, Zhang S, Wang Q, Anang S, et al
    Spike glycoprotein and host cell determinants of SARS-CoV-2 entry and cytopathic effects.
    J Virol. 2020 Dec 11. pii: JVI.02304-20. doi: 10.1128/JVI.02304.
    >> Share

  178. TAKAGI A, Matsui M
    Identification of HLA-A*02:01-restricted candidate epitopes derived from the non-structural polyprotein 1a of SARS-CoV-2 that may be natural targets of CD8(+) T cell recognition in vivo.
    J Virol. 2020 Dec 2. pii: JVI.01837-20. doi: 10.1128/JVI.01837.
    >> Share

  179. TAVARES RCA, Mahadeshwar G, Wan H, Huston NC, et al
    The global and local distribution of RNA structure throughout the SARS-CoV-2 genome.
    J Virol. 2020 Dec 2. pii: JVI.02190-20. doi: 10.1128/JVI.02190.
    >> Share

    November 2020
  180. PAHMEIER F, Neufeldt CJ, Cerikan B, Prasad V, et al
    A Versatile Reporter System to Monitor Virus Infected Cells and Its Application to Dengue Virus and SARS-CoV-2.
    J Virol. 2020 Nov 30. pii: JVI.01715-20. doi: 10.1128/JVI.01715.
    >> Share

  181. YUAN LX, Liang JQ, Zhu QC, Dai G, et al
    Gammacoronavirus Avian Infectious Bronchitis Virus and Alphacoronavirus Porcine Epidemic Diarrhea Virus Exploit a Cell-Survival Strategy via Upregulation of cFOS to Promote Viral Replication.
    J Virol. 2020 Nov 25. pii: JVI.02107-20. doi: 10.1128/JVI.02107.
    >> Share

  182. WESTERGREN JAKOBSSON A, Segerman B, Wallerman O, Lind SB, et al
    The Human Adenovirus Type 2 Transcriptome: An Amazing Complexity of Alternatively Spliced mRNAs.
    J Virol. 2020 Nov 25. pii: JVI.01869-20. doi: 10.1128/JVI.01869.
    >> Share

  183. CLARK LK, Green TJ, Petit CM
    Structure of nonstructural protein 1 from SARS-CoV-2.
    J Virol. 2020 Nov 24. pii: JVI.02019-20. doi: 10.1128/JVI.02019.
    >> Share

  184. MILEWSKA A, Chi Y, Szczepanski A, Barreto-Duran E, et al
    HTCC as a Polymeric Inhibitor of SARS-CoV-2 and MERS-CoV.
    J Virol. 2020 Nov 20. pii: JVI.01622-20. doi: 10.1128/JVI.01622.
    >> Share

  185. UJIKE M, Kawachi Y, Matsunaga Y, Etho Y, et al
    Characterization of localization and export signals of bovine torovirus nucleocapsid protein responsible for extensive nuclear and nucleolar accumulation and their importance for virus growth.
    J Virol. 2020 Nov 11. pii: JVI.02111-20. doi: 10.1128/JVI.02111.
    >> Share

  186. TANDON R, Sharp JS, Zhang F, Pomin VH, et al
    Effective Inhibition of SARS-CoV-2 Entry by Heparin and Enoxaparin Derivatives.
    J Virol. 2020 Nov 10. pii: JVI.01987-20. doi: 10.1128/JVI.01987.
    >> Share

  187. ALHAMMAD YMO, Kashipathy MM, Roy A, Gagne JP, et al
    The SARS-CoV-2 conserved macrodomain is a mono-ADP-ribosylhydrolase.
    J Virol. 2020 Nov 6. pii: JVI.01969-20. doi: 10.1128/JVI.01969.
    >> Share

  188. FENWICK C, Croxatto A, Coste AT, Pojer F, et al
    Changes in SARS-CoV-2 Spike versus Nucleoprotein Antibody Responses Impact the Estimates of Infections in Population-Based Seroprevalence Studies.
    J Virol. 2020 Nov 3. pii: JVI.01828-20. doi: 10.1128/JVI.01828.
    >> Share

  189. HEISE M, Dermody TS, Casadevall A, Sandri-Goldin RM, et al
    The Decision to Publish Gutierrez-Alvarez et al., "Middle East Respiratory Syndrome Coronavirus Gene 5 Modulates Pathogenesis in Mice".
    J Virol. 2020 Nov 3. pii: JVI.02118-20. doi: 10.1128/JVI.02118.
    >> Share

  190. GUTIERREZ-ALVAREZ J, Wang L, Fernandez-Delgado R, Li K, et al
    Middle East Respiratory Syndrome Coronavirus Gene 5 Modulates Pathogenesis in Mice.
    J Virol. 2020 Nov 3. pii: JVI.01172-20. doi: 10.1128/JVI.01172.
    >> Share

    October 2020
  191. DIEZ-FUERTES F, Iglesias-Caballero M, Garcia Perez J, Monzon S, et al
    A FOUNDER EFFECT LED EARLY SARS-COV-2 TRANSMISSION IN SPAIN.
    J Virol. 2020 Oct 30. pii: JVI.01583-20. doi: 10.1128/JVI.01583.
    >> Share

  192. MATSUYAMA S, Kawase M, Nao N, Shirato K, et al
    The inhaled steroid ciclesonide blocks SARS-CoV-2 RNA replication by targeting the viral replication-transcription complex in cultured cells.
    J Virol. 2020 Oct 14. pii: JVI.01648-20. doi: 10.1128/JVI.01648.
    >> Share

  193. LI Y, Yang N, Chen J, Huang X, et al
    Next-Generation Porcine Intestinal Organoids: an Apical-Out Organoid Model for Swine Enteric Virus Infection and Immune Response Investigations.
    J Virol. 2020;94.
    >> Share

    September 2020
  194. SYAGE AR, Ekiz HA, Skinner DD, Stone C, et al
    Single-cell RNA sequencing reveals the diversity of the immunological landscape following CNS infection by a murine coronavirus.
    J Virol. 2020 Sep 30. pii: JVI.01295-20. doi: 10.1128/JVI.01295.
    >> Share

  195. HU Y, Li W, Gao T, Cui Y, et al
    Correction for Hu et al., "The Severe Acute Respiratory Syndrome Coronavirus Nucleocapsid Inhibits Type I Interferon Production by Interfering with TRIM25-Mediated RIG-I Ubiquitination".
    J Virol. 2020;94.
    >> Share

  196. XU S, Zhou J, Chen Y, Tong X, et al
    Characterization of Self-Processing Activities and Substrate Specificities of Porcine Torovirus 3C-Like Protease.
    J Virol. 2020;94.
    >> Share

  197. CHOI JA, Goo J, Yang E, Jung DI, et al
    Cross-Protection against MERS-CoV by Prime-Boost Vaccination Using Viral Spike DNA and Protein.
    J Virol. 2020 Sep 23. pii: JVI.01176-20. doi: 10.1128/JVI.01176.
    >> Share

  198. OGANDO NS, Zevenhoven-Dobbe JC, van der Meer Y, Bredenbeek PJ, et al
    The enzymatic activity of the nsp14 exoribonuclease is critical for replication of MERS-CoV and SARS-CoV-2.
    J Virol. 2020 Sep 16. pii: JVI.01246-20. doi: 10.1128/JVI.01246.
    >> Share

  199. LOKUGAMAGE KG, Hage A, de Vries M, Valero-Jimenez AM, et al
    Type I interferon susceptibility distinguishes SARS-CoV-2 from SARS-CoV.
    J Virol. 2020 Sep 16. pii: JVI.01410-20. doi: 10.1128/JVI.01410.
    >> Share

  200. CHANDRASEKAR SS, Kingstad-Bakke B, Wu CW, Suresh M, et al
    A Novel Mucosal Adjuvant System for Immunization against Avian Coronavirus Causing Infectious Bronchitis.
    J Virol. 2020;94.
    >> Share

  201. BROCATO RL, Principe LM, Kim RK, Zeng X, et al
    Disruption of Adaptive Immunity Enhances Disease in SARS-CoV-2 Infected Syrian Hamsters.
    J Virol. 2020 Sep 8. pii: JVI.01683-20. doi: 10.1128/JVI.01683.
    >> Share

    August 2020
  202. LI Y, Wang H, Tang X, Fang S, et al
    SARS-CoV-2 and three related coronaviruses utilize multiple ACE2 orthologs and are potently blocked by an improved ACE2-Ig.
    J Virol. 2020 Aug 26. pii: JVI.01283-20. doi: 10.1128/JVI.01283.
    >> Share

  203. FROGGATT HM, Heaton BE, Heaton NS
    Development of a fluorescence based, high-throughput SARS-CoV-2 3CL(pro) reporter assay.
    J Virol. 2020 Aug 25. pii: JVI.01265-20. doi: 10.1128/JVI.01265.
    >> Share

  204. GUAN H, Wang Y, Perculija V, Saeed AFUH, et al
    Cryo-electron microscopy structure of the SADS-CoV spike glycoprotein provides insights into an evolution of unique coronavirus spike proteins.
    J Virol. 2020 Aug 19. pii: JVI.01301-20. doi: 10.1128/JVI.01301.
    >> Share

  205. WESTON S, Coleman CM, Haupt R, Logue J, et al
    Broad anti-coronaviral activity of FDA approved drugs against SARS-CoV-2 in vitro and SARS-CoV in vivo.
    J Virol. 2020 Aug 19. pii: JVI.01218-20. doi: 10.1128/JVI.01218.
    >> Share

  206. SI F, Chen B, Hu X, Yu R, et al
    Porcine Epidemic Diarrhea Virus ORF3 Protein Is Transported through the Exocytic Pathway.
    J Virol. 2020;94.
    >> Share

  207. HWANG M, Bergmann CC
    Neuronal ablation of IFNalpha/beta signaling exacerbates CNS viral dissemination and impairs IFNgamma responsiveness in microglia/macrophages.
    J Virol. 2020 Aug 12. pii: JVI.00422-20. doi: 10.1128/JVI.00422.
    >> Share

  208. JOHNSON MC, Lyddon TD, Suarez R, Salcedo B, et al
    Optimized pseudotyping conditions for the SARS COV-2 Spike glycoprotein.
    J Virol. 2020 Aug 11. pii: JVI.01062-20. doi: 10.1128/JVI.01062.
    >> Share

    July 2020
  209. GUO H, Hu BJ, Yang XL, Zeng LP, et al
    Evolutionary arms race between virus and host drives genetic diversity in bat SARS related coronavirus spike genes.
    J Virol. 2020 Jul 22. pii: JVI.00902-20. doi: 10.1128/JVI.00902.
    >> Share

  210. VANDERHEIDEN A, Ralfs P, Chirkova T, Upadhyay AA, et al
    Type I and Type III IFN Restrict SARS-CoV-2 Infection of Human Airway Epithelial Cultures.
    J Virol. 2020 Jul 22. pii: JVI.00985-20. doi: 10.1128/JVI.00985.
    >> Share

  211. WANG Y, Sun J, Li X, Zhu A, et al
    Increased Pathogenicity and Virulence of Middle East Respiratory Syndrome Coronavirus Clade B In Vitro and In Vivo.
    J Virol. 2020;94.
    >> Share

  212. AHLEN G, Frelin L, Nekoyan N, Weber F, et al
    The SARS-CoV-2 N protein is a good component in a vaccine.
    J Virol. 2020 Jul 13. pii: JVI.01279-20. doi: 10.1128/JVI.01279.
    >> Share

  213. ZHAO X, Chen D, Szabla R, Zheng M, et al
    Broad and differential animal ACE2 receptor usage by SARS-CoV-2.
    J Virol. 2020 Jul 13. pii: JVI.00940-20. doi: 10.1128/JVI.00940.
    >> Share

  214. SMITH M, Honce R, Schultz-Cherry S
    Metabolic Syndrome and Viral Pathogenesis: Lessons from Influenza and Coronaviruses.
    J Virol. 2020 Jul 13. pii: JVI.00665-20. doi: 10.1128/JVI.00665.
    >> Share

  215. TABOADA B, Vazquez-Perez JA, Munoz Medina JE, Ramos Cervantes P, et al
    Genomic Analysis of Early SARS-CoV-2 Variants Introduced in Mexico.
    J Virol. 2020 Jul 8. pii: JVI.01056-20. doi: 10.1128/JVI.01056.
    >> Share

  216. ZHAO X, Zheng S, Chen D, Zheng M, et al
    LY6E Restricts the Entry of Human Coronaviruses, Including the Currently Pandemic SARS-CoV-2.
    J Virol. 2020 Jul 8. pii: JVI.00562-20. doi: 10.1128/JVI.00562.
    >> Share

  217. DERVAS E, Hepojoki J, Smura T, Prahauser B, et al
    Serpentoviruses, more than respiratory pathogens.
    J Virol. 2020 Jul 8. pii: JVI.00649-20. doi: 10.1128/JVI.00649.
    >> Share

  218. CHAKRAVARTY D, Saadi F, Kundu S, Bose A, et al
    CD4 Deficiency Causes Poliomyelitis and Axonal Blebbing in Murine Coronavirus-Induced Neuroinflammation.
    J Virol. 2020;94.
    >> Share

  219. DALMANN A, Reimann I, Wernike K, Beer M, et al
    Autonomously Replicating RNAs of Bungowannah Pestivirus: E(RNS) Is Not Essential for the Generation of Infectious Particles.
    J Virol. 2020;94.
    >> Share

  220. YIN L, Chen J, Li L, Guo S, et al
    Aminopeptidase N Expression, Not Interferon Responses, Determines the Intestinal Segmental Tropism of Porcine Deltacoronavirus.
    J Virol. 2020;94.
    >> Share

    June 2020
  221. MOORE JP, Klasse PJ
    SARS-CoV-2 vaccines: 'Warp Speed' needs mind melds not warped minds.
    J Virol. 2020 Jun 26. pii: JVI.01083-20. doi: 10.1128/JVI.01083.
    >> Share

  222. LIU Z, Zheng H, Lin H, Li M, et al
    Identification of common deletions in the spike protein of SARS-CoV-2.
    J Virol. 2020 Jun 22. pii: JVI.00790-20. doi: 10.1128/JVI.00790.
    >> Share

  223. DENG X, Buckley AC, Pillatzki A, Lager KM, et al
    Inactivating Three Interferon Antagonists Attenuates Pathogenesis of an Enteric Coronavirus.
    J Virol. 2020 Jun 17. pii: JVI.00565-20. doi: 10.1128/JVI.00565.
    >> Share

  224. DUTTA NK, Mazumdar K, Gordy JT
    The Nucleocapsid Protein of SARS-CoV-2: a Target for Vaccine Development.
    J Virol. 2020;94.
    >> Share

  225. STRAUS MR, Tang T, Lai AL, Flegel A, et al
    Ca(2+) Ions Promote Fusion of Middle East Respiratory Syndrome Coronavirus with Host Cells and Increase Infectivity.
    J Virol. 2020;94.
    >> Share

  226. CHANG CY, Liu HM, Chang MF, Chang SC, et al
    Middle East Respiratory Syndrome Coronavirus Nucleocapsid Protein Suppresses Type I and Type III Interferon Induction by Targeting RIG-I Signaling.
    J Virol. 2020;94.
    >> Share

    May 2020
  227. LU Y, Cai H, Lu M, Ma Y, et al
    Porcine epidemic diarrhea virus deficient in RNA cap guanine-N-7 methylation is attenuated and induces higher type I and III interferon responses.
    J Virol. 2020 May 27. pii: JVI.00447-20. doi: 10.1128/JVI.00447.
    >> Share

  228. ZHU X, Chen J, Tian L, Zhou Y, et al
    Porcine Deltacoronavirus nsp5 Cleaves DCP1A to Decrease Its Antiviral Ability.
    J Virol. 2020 May 27. pii: JVI.02162-19. doi: 10.1128/JVI.02162.
    >> Share

  229. MILEWSKA A, Kula-Pacurar A, Wadas J, Suder A, et al
    Replication of SARS-CoV-2 in human respiratory epithelium.
    J Virol. 2020 May 20. pii: JVI.00957-20. doi: 10.1128/JVI.00957.
    >> Share

  230. VOLK A, Hackbart M, Deng X, Cruz-Pulido Y, et al
    Coronavirus Endoribonuclease and Deubiquitinating Interferon Antagonists Differentially Modulate the Host Response during Replication in Macrophages.
    J Virol. 2020;94.
    >> Share

  231. DENG X, Chen Y, Mielech AM, Hackbart M, et al
    Structure-Guided Mutagenesis Alters Deubiquitinating Activity and Attenuates Pathogenesis of a Murine Coronavirus.
    J Virol. 2020;94.
    >> Share

  232. ZHAI X, Sun J, Yan Z, Zhang J, et al
    Comparison of SARS-CoV-2 spike protein binding to ACE2 receptors from human, pets, farm animals, and putative intermediate hosts.
    J Virol. 2020 May 13. pii: JVI.00831-20. doi: 10.1128/JVI.00831.
    >> Share

  233. ZHU Y, Yu D, Yan H, Chong H, et al
    Design of potent membrane fusion inhibitors against SARS-CoV-2, an emerging coronavirus with high fusogenic activity.
    J Virol. 2020 May 6. pii: JVI.00635-20. doi: 10.1128/JVI.00635.
    >> Share

  234. HOLLAND LA, Kaelin EA, Maqsood R, Estifanos B, et al
    An 81 nucleotide deletion in SARS-CoV-2 ORF7a identified from sentinel surveillance in Arizona (Jan-Mar 2020).
    J Virol. 2020 May 1. pii: JVI.00711-20. doi: 10.1128/JVI.00711.
    >> Share

    April 2020
  235. NGUYEN A, David JK, Maden SK, Wood MA, et al
    Human leukocyte antigen susceptibility map for SARS-CoV-2.
    J Virol. 2020 Apr 17. pii: JVI.00510-20. doi: 10.1128/JVI.00510.
    >> Share

  236. WANG M, Li M, Ren R, Li L, et al
    International expansion of a novel SARS-CoV-2 mutant.
    J Virol. 2020 Apr 8. pii: JVI.00567-20. doi: 10.1128/JVI.00567.
    >> Share

  237. LICASTRO D, Rajasekharan S, Dal Monego S, Segat L, et al
    Isolation and full-length genome characterization of SARS-CoV-2 from COVID-19 cases in Northern Italy.
    J Virol. 2020 Apr 1. pii: JVI.00543-20. doi: 10.1128/JVI.00543.
    >> Share

  238. CAGLIANI R, Forni D, Clerici M, Sironi M, et al
    Computational inference of selection underlying the evolution of the novel coronavirus, SARS-CoV-2.
    J Virol. 2020 Apr 1. pii: JVI.00411-20. doi: 10.1128/JVI.00411.
    >> Share

    January 2020
  239. WAN Y, Shang J, Graham R, Baric RS, et al
    Receptor recognition by novel coronavirus from Wuhan: An analysis based on decade-long structural studies of SARS.
    J Virol. 2020 Jan 29. pii: JVI.00127-20. doi: 10.1128/JVI.00127.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016